The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

Biology and Medicine

Volumn 1, Issue 2, 2009, Pages 61-65

  Estari, M ^a   Reddy, A S ^a   Bikshapathi, T ^a   Satyanarayana, J ^a   Venkanna, L ^a   Reddy, M K ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Andhra Pradesh; Dyslipidemia; India; Serum lipids; Urban adult population

Indexed keywords

EID: 84863870118     PISSN: None     EISSN: 09748369     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Feng Y, Wang H, Du S, and Popkin B.B. The changing trend of dietary pattern of Chinese population-eight provinces cases study in China (Chinese). Acta Nutrition Sin, 24, 342-346 (2002).
2. Frick M.H, Elo O, Haapa K, Heinonen OP, Heinsalmi P and Helo P, Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety and treatment, changes in risk factors and incidence of coronary heart disease. New England Journal of Medicine, 317, 1237-1245 (1987).
3. Genest J.J, McNamara J.R, Salem D.N and Schaefer E.J. Prevalence of risk factors in men with premature coronary heart disease. American Journal of Cardiology, 67,1185-1189 (1991).
4. Gordon T, Castelli W.P, Hjortland M.C, Kannel W.B and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. American Journal of Medicine, 62, 707-714 (1977).
5. Kannel W.B, Castelli W.P and Gordon. T. Lipoprotein cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham Heart Study. Annals of Internal Medicine, 90, 85-91 (1979).
6. Lewis B, Assmann G, Tikkanen M, Mancini M and Pometta D. Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society, prepared by the International Task Force for Prevention of Coronary Heart Disease. Nutrition, Metabolism and Cardiovascular Diseases, 2, 113-156 (1992).
7. Martin M.J, Hulley S.B, Browner W.S, Kuller L.H and Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361662 men. Lancet, 2,933-936 (1986).
8. Rhoads G.G, Gulbrandsen C.L, Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaiian Japanese men. New England Journal of Medicine, 294, 293-298 (1976).
9. The Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Journal of the American Medical Association, 269, 3015-23 (1993).
10. Wang Z, Ning T, Shao G, Chen Z, Lu Z, et al. Recommendations for prevention and treatment of dyslipidemia. Chinese Journal of Cardiology, 25, 169-175 (1997).
11. World Health Organization Working Groups. Use and interpretation of anthropometric indicators of nutritional status. Bulletin of World Health Organization, 64, 929-941 (1986).